Natalie Fischer

Dr. Natalie Fischer

Sciensano, Brussels, Belgium
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in Seminars in Immunology
Verified
Journal Article
Closed access
BSBrice Sperandio
Brice Sperandio
Natalie FischerNatalie Fischer
Natalie Fischer
PSPhilippe J. Sansonetti
Philippe J. Sansonetti

9 May 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
Natalie FischerNatalie Fischer
Natalie Fischer
ESEmmanuel Sechet
Emmanuel Sechet
RFRobin Friedman
Robin Friedman
AAAurélien Amiot
Aurélien Amiot
ISIradj Sobhani
Iradj Sobhani
BSBrice Sperandio
Brice Sperandio
Antimicrobial peptides (AMP) are defense effectors of the innate immunity playing a crucial role in the intestinal homeostasis with commensals and protection against pathogens. Herein we aimed to investigate AMP gene regulation by deciphering specific characteristics allowing their enhanced expression among innate immune genes, particularly those encoding proinflammatory mediators. Our emphasis was on epigenetic regulation of the gene encoding the AMP β-defensin 2 (HBD2), taken as a model of possibly specific induction, upon challenge with a commensal bacterium, compared with the proinflammatory cytokine IL-8. Using an in vitro model of colonic epithelial cells challenged with Escherichia coli K12, we showed that inhibition of histone deacetylases (HDAC) by trichostatin A dramatically enhanced induction of HBD2 expression, without affecting expression of IL-8. This mechanism was supported by an increased phosphorylation of histone H3 on serine S10, preferentially at the HBD2 promoter. This process occurred through activation of the IκB kinase complex, which also led to activation of NF-κB. Moreover, we demonstrated that NF-κB was modified by acetylation upon HDAC inhibition, partly by the histone acetyltransferase p300, and that both NF-κB and p300 supported enhanced induction of HBD2 expression. Furthermore, we identified additional genes belonging to antimicrobial defense and epithelial restitution pathways that showed a similar pattern of epigenetic control. Finally, we confirmed our finding in human colonic primary cells using an ex vivo organoid model. This work opens the way to use epigenetic pharmacology to achieve induction of epithelial antimicrobial defenses, while limiting the deleterious risk of an inflammatory response.

1 January 2013 in BioMed Research International
Verified
Journal Article
Open access
PDF file
Natalie FischerNatalie Fischer
Natalie Fischer
TMTim N. Mak
Tim N. Mak
DSDebika Biswal Shinohara
Debika Biswal Shinohara
KSKaren S. Sfanos
Karen S. Sfanos
TMThomas Meyer
Thomas Meyer
HBHolger Bruggemann
Holger Bruggemann
Propionibacterium acnesis a Gram-positive bacterium that colonizes various niches of the human body, particularly the sebaceous follicles of the skin. Over the last years a role of this common skin bacterium as an opportunistic pathogen has been explored. Persistence ofP. acnesin host tissue has been associated with chronic inflammation and disease development, for example, in prostate pathologies. This study investigated the intracellular fate ofP. acnesin macrophages after phagocytosis. In a mouse model ofP. acnes-induced chronic prostatic inflammation, the bacterium could be detected in prostate-infiltrating macrophages at 2 weeks postinfection. Further studies performed in the human macrophage cell line THP-1 revealed intracellular survival and persistence ofP. acnesbut no intracellular replication or escape from the host cell. Confocal analyses of phagosome acidification and maturation were performed. Acidification ofP. acnes-containing phagosomes was observed at 6 h postinfection but then lost again, indicative of cytosolic escape ofP. acnesor intraphagosomal pH neutralization. No colocalization with the lysosomal markers LAMP1 and cathepsin D was observed, implying that theP. acnes-containing phagosome does not fuse with lysosomes. Our findings give first insights into the intracellular fate ofP. acnes; its persistency is likely to be important for the development ofP. acnes-associated inflammatory diseases.

3 July 2012 in Cellular Microbiology
Verified
Journal Article
Open access
PDF file
TMTim N. Mak
Tim N. Mak
Natalie FischerNatalie Fischer
Natalie Fischer
BLBritta Laube
Britta Laube
VBVolker Brinkmann
Volker Brinkmann
MMMatteo M. E. Metruccio
Matteo M. E. Metruccio
HBHolger Bruggemann
Holger Bruggemann
The contribution of the human microbiota to health and disease is poorly understood. Propionibacterium acnes is a prominent member of the skin microbiota, but is also associated with acne vulgaris. This bacterium has gained recent attention as a potential opportunistic pathogen at non-skin infection sites due to its association with chronic pathologies and its isolation from diseased prostates. We performed comparative global-transcriptional analyses for P. acnes infection of keratinocytes and prostate cells. P. acnes induced an acute, transient transcriptional inflammatory response in keratinocytes, whereas this response was delayed and sustained in prostate cells. We found that P. acnes invaded prostate epithelial cells, but not keratinocytes, and was detectable intracellularly 7 days post infection. Further characterization of the host cell response to infection revealed that vimentin was a key determinant for P. acnes invasion in prostate cells. siRNA-mediated knock-down of vimentin in prostate cellsattenuated bacterial invasion and the inflammatory response to infection. We conclude that host cell tropism, which may depend on the host protein vimentin, is relevant for P. acnes invasion and in part determines its sustained inflammatory capacity and persistence of infection.

1 November 2008 in Molecular and Cellular Neuroscience
Verified
Journal Article
Closed access
TGThomas Grampp
Thomas Grampp
VNValerie Notz
Valerie Notz
IBIlja Broll
Ilja Broll
Natalie FischerNatalie Fischer
Natalie Fischer
DBDietmar Benke
Dietmar Benke

1 October 2013 in Infection and Immunity
Verified
Journal Article
Open access
PDF file
BSBrice Sperandio
Brice Sperandio
Natalie FischerNatalie Fischer
Natalie Fischer
MJMarie Joncquel
Marie Joncquel
YRYannick Rossez
Yannick Rossez
PRPascal Roux
Pascal Roux
PSPhilippe J. Sansonetti
Philippe J. Sansonetti
Mucin glycoproteins are secreted in large amounts by the intestinal epithelium and constitute an efficient component of innate immune defenses to promote homeostasis and protect against enteric pathogens. In this study, our objective was to investigate how the bacterial enteropathogen Shigella flexneri , which causes bacillary dysentery, copes with the mucin defense barrier. We report that upon in vitro infection of mucin-producing polarized human intestinal epithelial cells, virulent S. flexneri manipulates the secretion of gel-forming mucins. This phenomenon, which is triggered only by virulent strains, results in accumulation of mucins at the cell apical surface, leading to the appearance of a gel-like structure that favors access of bacteria to the cell surface and the subsequent invasion process. We identify MUC5AC, a gel-forming mucin, as a component of this structure. Formation of this gel does not depend on modifications of electrolyte concentrations, induction of trefoil factor expression, endoplasmic reticulum stress, or response to unfolded proteins. In addition, transcriptional and biochemical analyses of infected cells reveal modulations of mucin gene expression and modifications of mucin glycosylation patterns, both of which are induced by virulent bacteria in a type III secretion system-dependent manner. Thus, S. flexneri has developed a dedicated strategy to alter the mucus barrier by targeting key elements of the gel-forming capacity of mucins: gene transcription, protein glycosylation, and secretion.